Cell culture media for fibroblasts offered by PELOBiotech

We offer a lot in the field of cell culture media for fibroblasts, but what else does PELOBiotech offer?

We are more than competence4cells – especially when it comes to cultivating connective tissue’s most versatile cells.

Fibroblasts are key players in maintaining the extracellular matrix, driving wound healing, and supporting tissue integrity.

With our specialized media, you can culture fibroblasts from various tissues—ensuring optimal growth, protein synthesis, and functionality.

Our formulations are tailored to preserve fibroblast adaptability and vitality across applications from regenerative medicine to reprogramming studies.

Trust PELOBiotech to deliver the right media solutions for robust, reproducible fibroblast cultures.

Filter products

Fibroblasts PELOBiotech GmbH

Synoviocyte growth medium (500 ml)

Supplier
Cellapplications

Catalog Number
PB-415-500

More Details
Fibroblasts PELOBiotech GmbH

Synoviocyte growth medium kit (500 ml)

Supplier
Cellapplications

Catalog Number
PB-415K-500

More Details
Fibroblasts PELOBiotech GmbH

Synoviocyte growth medium without antibiotics (500 ml)

Supplier
Cellapplications

Catalog Number
PB-415A-500

More Details
Fibroblasts PELOBiotech GmbH

Synoviocyte growth medium without fbs (500 ml)

Supplier
Cellapplications

Catalog Number
PB-415F-500

More Details
Fibroblasts PELOBiotech GmbH

Synoviocyte growth supplement (50 ml)

Supplier
Cellapplications

Catalog Number
PB-415-GS

More Details
Fibroblasts PELOBiotech GmbH

Xyltech growth h-fbro

Supplier
Funakoshi

Catalog Number
87-282

More Details
Fibroblasts PELOBiotech GmbH

Xyltech h-fbro-01

Supplier
Funakoshi

Catalog Number
87-281

More Details

Optimized media for fibroblast culture and research

PELOBiotech offers specialized media to support the growth, functionality, and adaptability of fibroblasts from diverse tissue origins. Our solutions promote stable extracellular matrix production and enable reliable results in wound healing, regenerative medicine, and cellular reprogramming research.